Dave Williamson
XMFGreenwave4
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Recent Articles by Dave Williamson

Apr 7, 2017
by Dave Williamson
Why the Dow Popped
Earnings, earnings, earnings.

Apr 7, 2017
by Dave Williamson
1 Biotech With Room to Run

Apr 7, 2017
by Dave Williamson
1 Dividend to Buy, 1 Dividend to Sell (AZN, XOM)

Apr 7, 2017
by Dave Williamson
Are These 2 Biotechs About to Be Bought?

Apr 7, 2017
by Dave Williamson
Charting a Course to Profit

Apr 7, 2017
by Dave Williamson
Investors Pile Into Arena

Apr 7, 2017
by Dave Williamson
Will the Supreme Court Overturn Your Portfolio?

Apr 7, 2017
by Dave Williamson
Dow Smackdown: Cisco vs. ExxonMobil

Apr 7, 2017
by Dave Williamson
Dow Smackdown: JPMorgan vs. ExxonMobil
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.